Lonafarnib for Chronic Hepatitis D

Summary

Lonafarnib for Chronic Hepatitis D is a clinical trial^[1].

Key Facts

• Lonafarnib for Chronic Hepatitis D is in the country of United States^[2].
• Lonafarnib for Chronic Hepatitis D's instance of is recorded as clinical trial^[3].
• Lonafarnib for Chronic Hepatitis D's start time is recorded as +2011-12-31T00:00:00Z^[4].
• Lonafarnib for Chronic Hepatitis D's end time is recorded as +2015-04-30T00:00:00Z^[5].
• Lonafarnib for Chronic Hepatitis D's sponsor is recorded as National Institute of Diabetes and Digestive and Kidney Diseases^[6].
• Lonafarnib for Chronic Hepatitis D's main subject is recorded as hepatitis D^[7].
• Lonafarnib for Chronic Hepatitis D's main subject is recorded as hepatitis^[8].
• Lonafarnib for Chronic Hepatitis D's main subject is recorded as hepatitis A^[9].
• Lonafarnib for Chronic Hepatitis D's number of participants is recorded as {'unit': '1', 'amount': '+14'}^[10].
• Lonafarnib for Chronic Hepatitis D's title is recorded as Treatment of Chronic Delta Hepatitis With Lonafarnib^[11].
• Lonafarnib for Chronic Hepatitis D's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[12].
• Lonafarnib for Chronic Hepatitis D's ClinicalTrials.gov ID is recorded as NCT01495585^[13].
• Lonafarnib for Chronic Hepatitis D's research intervention is recorded as lonafarnib^[14].
• Lonafarnib for Chronic Hepatitis D's clinical trial phase is recorded as phase II clinical trial^[15].
• Lonafarnib for Chronic Hepatitis D's research site is recorded as United States National Institutes of Health^[16].
• Lonafarnib for Chronic Hepatitis D's research subject recruitment status is recorded as completed^[17].
• Lonafarnib for Chronic Hepatitis D's study type is recorded as interventional study^[18].